Functional Integration of the Conserved Domains of Shoc2 Scaffold

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jeoung, Myoungkun ^a   Abdelmoti, Lina ^a   Jang, Eun Ryoung ^a   Vander Kooi, Craig W ^a   Galperin, Emilia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LEUCINE; M RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; RAF PROTEIN; RAS PROTEIN; REGULATOR PROTEIN; SHOC2 PROTEIN; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN BINDING; SHOC2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; ENDOSOME; ENZYME ACTIVITY; ENZYME KINETICS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CHLOROCEBUS AETHIOPS; CONSERVED SEQUENCE; CV-1 CELL LINE; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; CONSERVED SEQUENCE; COS CELLS; EPIDERMAL GROWTH FACTOR; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, MOLECULAR; MONOMERIC GTP-BINDING PROTEINS; PROTEIN BINDING; PROTEIN DOMAINS; PROTO-ONCOGENE PROTEINS C-RAF; RNA INTERFERENCE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 84879262862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066067     Document Type: Article

References (58)

1. Pullikuth AK, Catling AD, (2007) Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cellular signalling 19: 1621-1632.
2. Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, et al. (2011) Raf family kinases: old dogs have learned new tricks. Genes Cancer 2: 232-260.
3. Kholodenko BN, Hancock JF, Kolch W, (2010) Signalling ballet in space and time. Nature reviews Molecular cell biology 11: 414-426.
4. Zeke A, Lukacs M, Lim WA, Remenyi A, (2009) Scaffolds: interaction platforms for cellular signalling circuits. Trends in cell biology 19: 364-374.
5. Park SH, Zarrinpar A, Lim WA, (2003) Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms. Science 299: 1061-1064.
6. Kolch W, (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. The Biochemical journal 351 Pt 2: 289-305.
7. Nguyen A, Burack WR, Stock JL, Kortum R, Chaika OV, et al. (2002) Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Molecular and cellular biology 22: 3035-3045.
8. Claperon A, Therrien M, (2007) KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene 26: 3143-3158.
9. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP, (2007) Scaffold proteins of MAP-kinase modules. Oncogene 26: 3185-3202.
10. Brown MD, Sacks DB, (2009) Protein scaffolds in MAP kinase signalling. Cellular signalling 21: 462-469.
11. Brown MD, Sacks DB (2008) Compartmentalised MAPK pathways. Handbook of experimental pharmacology: 205-235.
12. Morrison DK, Davis RJ, (2003) Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annual review of cell and developmental biology 19: 91-118.
13. Good MC, Zalatan JG, Lim WA, (2011) Scaffold proteins: hubs for controlling the flow of cellular information. Science 332: 680-686.
14. Berridge MJ (2012) Cell Signaling Biology.
15. Therrien M, Michaud NR, Rubin GM, Morrison DK, (1996) KSR modulates signal propagation within the MAPK cascade. Genes & development 10: 2684-2695.
16. Therrien M, Chang HC, Solomon NM, Karim FD, Wassarman DA, et al. (1995) KSR, a novel protein kinase required for RAS signal transduction. Cell 83: 879-888.
17. Kolch W, (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nature reviews Molecular cell biology 6: 827-837.
18. Selfors LM, Schutzman JL, Borland CZ, Stern MJ, (1998) soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling. Proceedings of the National Academy of Sciences of the United States of America 95: 6903-6908.
19. Sieburth DS, Sun Q, Han M, (1998) SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 94: 119-130.
20. Li W, Han M, Guan KL, (2000) The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes & development 14: 895-900.
21. Herreros L, Rodriguez-Fernandez JL, Brown MC, Alonso-Lebrero JL, Cabanas C, et al. (2000) Paxillin localizes to the lymphocyte microtubule organizing center and associates with the microtubule cytoskeleton. The Journal of biological chemistry 275: 26436-26440.
22. Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F, (2006) A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Molecular cell 22: 217-230.
23. Matsunaga-Udagawa R, Fujita Y, Yoshiki S, Terai K, Kamioka Y, et al. (2010) The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf. The Journal of biological chemistry 285: 7818-7826.
24. Yoshiki S, Matsunaga-Udagawa R, Aoki K, Kamioka Y, Kiyokawa E, et al. (2010) Ras and calcium signaling pathways converge at Raf1 via the Shoc2 scaffold protein. Molecular biology of the cell 21: 1088-1096.
25. Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, et al. (2009) Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nature genetics 41: 1022-1026.
26. Yi J, Chen M, Wu X, Yang X, Xu T, et al. (2010) Endothelial SUR-8 acts in an ERK-independent pathway during atrioventricular cushion development. Developmental dynamics: an official publication of the American Association of Anatomists 239: 2005-2013.
27. Galperin E, Abdelmoti L, Sorkin A, (2012) Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells. PloS one 7: e36469.
28. Bella J, Hindle KL, McEwan PA, Lovell SC, (2008) The leucine-rich repeat structure. Cell Mol Life Sci 65: 2307-2333.
29. Ko J, Kim E, (2007) Leucine-rich repeat proteins of synapses. J Neurosci Res 85: 2824-2832.
30. Istomin AY, Godzik A, (2009) Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs. BMC Immunol 10: 48.
31. Kajava AV, (1998) Structural diversity of leucine-rich repeat proteins. Journal of molecular biology 277: 519-527.
32. Wezner-Ptasinska M, Krowarsch D, Otlewski J, (2011) Design and characteristics of a stable protein scaffold for specific binding based on variable lymphocyte receptor sequences. Biochim Biophys Acta 1814: 1140-1145.
33. Kobe B, Deisenhofer J, (1993) Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366: 751-756.
34. Kobe B, Kajava AV, (2000) When protein folding is simplified to protein coiling: the continuum of solenoid protein structures. Trends in biochemical sciences 25: 509-515.
35. Park H, Huxley-Jones J, Boot-Handford RP, Bishop PN, Attwood TK, et al. (2008) LRRCE: a leucine-rich repeat cysteine capping motif unique to the chordate lineage. BMC Genomics 9: 599.
36. Ceulemans H, De Maeyer M, Stalmans W, Bollen M, (1999) A capping domain for LRR protein interaction modules. FEBS letters 456: 349-351.
37. Ehrhardt GR, Leslie KB, Lee F, Wieler JS, Schrader JW, (1999) M-Ras, a widely expressed 29-kD homologue of p21 Ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line. Blood 94: 2433-2444.
38. Kobe B, Kajava AV, (2001) The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11: 725-732.
39. Kajava AV, (2001) Review: proteins with repeated sequence - structural prediction and modeling. J Struct Biol 134: 132-144.
40. Matsushima N, Tachi N, Kuroki Y, Enkhbayar P, Osaki M, et al. (2005) Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases. Cell Mol Life Sci 62: 2771-2791.
41. Denouel-Galy A, Douville EM, Warne PH, Papin C, Laugier D, et al. (1998) Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Current biology: CB 8: 46-55.
42. Joneson T, Fulton JA, Volle DJ, Chaika OV, Bar-Sagi D, et al. (1998) Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors. The Journal of biological chemistry 273: 7743-7748.
43. Sugimoto T, Stewart S, Han M, Guan KL, (1998) The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation. The EMBO journal 17: 1717-1727.
44. Cacace AM, Michaud NR, Therrien M, Mathes K, Copeland T, et al. (1999) Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Molecular and cellular biology 19: 229-240.
45. Teis D, Wunderlich W, Huber LA, (2002) Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Developmental cell 3: 803-814.
46. Wunderlich W, Fialka I, Teis D, Alpi A, Pfeifer A, et al. (2001) A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. The Journal of cell biology 152: 765-776.
47. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, et al. (1998) MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281: 1668-1671.
48. Sharma C, Vomastek T, Tarcsafalvi A, Catling AD, Schaeffer HJ, et al. (2005) MEK partner 1 (MP1): regulation of oligomerization in MAP kinase signaling. J Cell Biochem 94: 708-719.
49. Galperin E, Sorkin A, (2005) Visualization of Rab5 activity in living cells using FRET microscopy. Methods in enzymology 403: 119-134.
50. Galperin E, Sorkin A, (2008) Endosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosis. Traffic 9: 1776-1790.
51. Kim HM, Oh SC, Lim KJ, Kasamatsu J, Heo JY, et al. (2007) Structural diversity of the hagfish variable lymphocyte receptors. J Biol Chem 282: 6726-6732.
52. She J, Han Z, Kim TW, Wang J, Cheng W, et al. (2011) Structural insight into brassinosteroid perception by BRI1. Nature 474: 472-476.
53. Arnold K, Bordoli L, Kopp J, Schwede T, (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201.
54. Kelley LA, Sternberg MJ, (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4: 363-371.
55. Emsley P, Lohkamp B, Scott WG, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501.
56. Koradi R, Billeter M, Wuthrich K, (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graphics 14: 51-55.
57. Sorkin A, Duex JE (2010) Quantitative analysis of endocytosis and turnover of epidermal growth factor (EGF) and EGF receptor. Current protocols in cell biology/editorial board, Juan S Bonifacino [et al] Chapter 15: Unit 15 14.
58. Jiang X, Sorkin A, (2003) Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic 4: 529-543.